Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
FDA Approves Ridgeback Biotherapeutics to Begin Human Testing of Potential Treatment for COVID-19 Medical Countermeasures April 7, 2020 …
INOVIO Initiates Phase 1 Clinical Trial of COVID-19 Vaccine Candidate Medical Countermeasures April 7, 2020 …
BARDA and Genentech to Accelerate Phase 3 Clinical Trial of a Novel COVID-19 Therapeutic Treatment Industry News April 6, 2020 …
Amgen and Adaptive Biotechnologies Announce Collaboration to Develop a Therapeutic to Prevent or Treat COVID-19 Medical Countermeasures April 2, 2020 …
Emergent BioSolutions Partners with BARDA to Expedite Development of Plasma-Derived Therapy for COVID-19 Medical Countermeasures April 2, 2020 …
Celularity Announces FDA Clearance of IND Application for CYNK-001 in Coronavirus, First in Cellular Therapy Medical Countermeasures April 2, 2020 …
Tests in Engineered Human Tissues Show hrsACE2 Drug Blocked Early Stages of SARS-CoV-2 Infection Medical Countermeasures April 2, 2020 …
Hydroxychloroquine and Azythromycine Combo Treatment for COVID Can Raise Risk for Dangerous Abnormal Heart Rhythms Medical Countermeasures April 2, 2020 …
JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic Medical Countermeasures April 1, 2020 …
Sanofi and Translate Bio Team Up to Develop Novel Coronavirus mRNA Vaccine Medical Countermeasures March 28, 2020 …
Mapping Risks to the Drug Supply Chain During COVID-19 Pandemic: Critical Shortages Likely in U.S. Medical Countermeasures March 28, 2020 …
5 Questions Answered About Chloroquine: An Unproven Drug Against Coronavirus Medical Countermeasures March 25, 2020 …
WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment Medical Countermeasures March 25, 2020 …
FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients Medical Countermeasures March 24, 2020 …
Why Don’t We Have Drugs to Treat COVID-19 and How Long Will It Take to Develop Them? Medical Countermeasures March 21, 2020 …
Ridgeback Biotherapeutics and DRIVE Partner to Develop Clinical Stage Coronavirus Treatment Medical Countermeasures March 19, 2020 …
Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19 Medical Countermeasures March 18, 2020 …
PharmaJet Receives $9.6 Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices Medical Countermeasures March 17, 2020 …
